| Primary |
| Type 1 Diabetes Mellitus |
19.2% |
| Type 2 Diabetes Mellitus |
16.2% |
| Diabetes Mellitus |
14.5% |
| Insulin-requiring Type 2 Diabetes Mellitus |
11.7% |
| Product Used For Unknown Indication |
9.7% |
| Drug Use For Unknown Indication |
6.1% |
| Hypertension |
4.7% |
| Insulin-requiring Type Ii Diabetes Mellitus |
3.2% |
| Diabetes Mellitus Insulin-dependent |
3.1% |
| Cardiac Disorder |
1.5% |
| Blood Cholesterol Increased |
1.5% |
| Chronic Obstructive Pulmonary Disease |
1.4% |
| Ill-defined Disorder |
1.2% |
| Gastrooesophageal Reflux Disease |
1.2% |
| Depression |
0.9% |
| Asthma |
0.9% |
| Hypothyroidism |
0.9% |
| Blood Pressure Increased |
0.8% |
| Cardiac Failure Congestive |
0.7% |
| Neuropathy Peripheral |
0.7% |
|
| Blood Glucose Increased |
22.6% |
| Diabetic Ketoacidosis |
10.1% |
| Hypoglycaemic Unconsciousness |
9.1% |
| Hypoglycaemia |
5.9% |
| Wrong Drug Administered |
5.9% |
| Blood Glucose Decreased |
5.7% |
| Drug Ineffective |
5.0% |
| Loss Of Consciousness |
4.1% |
| Vomiting |
3.8% |
| Hypoglycaemic Coma |
3.3% |
| Hypersensitivity |
3.1% |
| Product Quality Issue |
3.1% |
| Pharmaceutical Product Complaint |
2.7% |
| Weight Increased |
2.7% |
| Hypoglycaemic Seizure |
2.6% |
| Incorrect Dose Administered |
2.1% |
| Urticaria |
2.1% |
| Device Malfunction |
2.0% |
| Myocardial Infarction |
2.0% |
| Cerebrovascular Accident |
1.9% |
|
| Secondary |
| Type 2 Diabetes Mellitus |
33.9% |
| Diabetes Mellitus |
13.3% |
| Type 1 Diabetes Mellitus |
11.3% |
| Product Used For Unknown Indication |
10.9% |
| Insulin-requiring Type 2 Diabetes Mellitus |
6.1% |
| Drug Use For Unknown Indication |
4.9% |
| Hypertension |
4.5% |
| Insulin-requiring Type Ii Diabetes Mellitus |
3.4% |
| Diabetes Mellitus Insulin-dependent |
2.1% |
| Blood Cholesterol Increased |
1.2% |
| Foetal Exposure During Pregnancy |
1.1% |
| Gastrooesophageal Reflux Disease |
1.1% |
| Depression |
1.0% |
| Neuropathy Peripheral |
0.9% |
| Asthma |
0.9% |
| Blood Pressure |
0.8% |
| Pain |
0.7% |
| Cardiac Disorder |
0.7% |
| Chronic Obstructive Pulmonary Disease |
0.7% |
| Diabetes Mellitus Non-insulin-dependent |
0.6% |
|
| Blood Glucose Increased |
25.0% |
| Weight Increased |
9.0% |
| Hypoglycaemia |
7.3% |
| Vomiting |
6.8% |
| Weight Decreased |
6.4% |
| Blood Glucose Decreased |
4.9% |
| Wrong Drug Administered |
4.7% |
| Hypoglycaemic Unconsciousness |
3.8% |
| Diabetic Ketoacidosis |
3.7% |
| Nausea |
3.5% |
| Myocardial Infarction |
3.1% |
| Visual Impairment |
2.8% |
| Blood Glucose Fluctuation |
2.6% |
| Death |
2.4% |
| Drug Ineffective |
2.4% |
| Injection Site Pain |
2.4% |
| Hyperhidrosis |
2.3% |
| Loss Of Consciousness |
2.3% |
| Malaise |
2.3% |
| Pancreatitis |
2.3% |
|
| Concomitant |
| Product Used For Unknown Indication |
35.3% |
| Drug Use For Unknown Indication |
17.4% |
| Diabetes Mellitus |
12.6% |
| Type 2 Diabetes Mellitus |
7.9% |
| Hypertension |
5.5% |
| Pain |
2.8% |
| Diabetes Mellitus Non-insulin-dependent |
2.1% |
| Type 1 Diabetes Mellitus |
1.9% |
| Depression |
1.9% |
| Prophylaxis |
1.5% |
| Blood Cholesterol Increased |
1.4% |
| Gastrooesophageal Reflux Disease |
1.3% |
| Cardiac Disorder |
1.3% |
| Rheumatoid Arthritis |
1.1% |
| Chronic Obstructive Pulmonary Disease |
1.1% |
| Multiple Myeloma |
1.1% |
| Nuclear Magnetic Resonance Imaging |
1.0% |
| Anxiety |
1.0% |
| Asthma |
0.9% |
| Blood Pressure |
0.9% |
|
| Weight Decreased |
16.7% |
| Vomiting |
13.8% |
| Blood Glucose Increased |
10.9% |
| Nausea |
7.3% |
| Weight Increased |
7.0% |
| Drug Ineffective |
4.4% |
| Death |
4.0% |
| Myocardial Infarction |
3.9% |
| Urinary Tract Infection |
3.6% |
| Off Label Use |
3.1% |
| Pneumonia |
2.9% |
| Tremor |
2.8% |
| Pain |
2.7% |
| Pancreatitis |
2.7% |
| Injection Site Pain |
2.6% |
| Renal Failure Acute |
2.4% |
| Vision Blurred |
2.4% |
| Renal Failure |
2.4% |
| Pruritus |
2.3% |
| Pain In Extremity |
2.2% |
|
| Interacting |
| Type 1 Diabetes Mellitus |
14.3% |
| Anxiety |
7.1% |
| Depression |
7.1% |
| Diarrhoea |
7.1% |
| Fibromyalgia |
7.1% |
| Gastrooesophageal Reflux Disease |
7.1% |
| Headache |
7.1% |
| Hypertension |
7.1% |
| Impaired Gastric Emptying |
7.1% |
| Neuralgia |
7.1% |
| Pain |
7.1% |
| Pain In Extremity |
7.1% |
| Thrombosis Prophylaxis |
7.1% |
|
| Drug Interaction |
33.3% |
| Loss Of Consciousness |
33.3% |
| Vomiting |
33.3% |
|
